We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Credit Rating (CRISIL)
Crisil AA-/Stable
Rates the company's debt-servicing ability — not the quality or value of its shares.
Rated: 20 May 2025
This rating is over a year old.
View Full Report52-Week Range
Valuation
Financials (FY2024)
Source: CRISILInvestment Thesis
Indofil Industries Limited is one of India's most established agrochemical companies with a 60+ year legacy, strong global footprint in 70+ countries, and leadership in fungicide production as part of the K.K. Modi Group. While regulatory headwinds around certain fungicides in developed markets pose a challenge, growing agricultural demand in emerging economies and the company's vertically integrated manufacturing provide a solid long-term growth base.
Pros
Cons
Business Segments
Agrochemicals - Fungicides
Manufacturing and marketing of fungicides including Mancozeb and Propineb for crop protection globally
Agrochemicals - Insecticides & Herbicides
Production of insecticides and herbicides for the domestic and international markets
Specialty & Industrial Chemicals
Chemicals used in rubber, PVC, leather and other industrial applications
Revenue Model
Indofil earns revenue primarily through manufacturing and sale of crop protection chemicals (fungicides, insecticides, herbicides) to domestic agricultural markets and through exports to 70+ countries. Revenue is driven by seasonal agricultural demand, crop cycles, and global agrochemical pricing.
Detailed Analysis
Growth Plans
Expansion of product portfolio into biological and organic crop protection segments
Growing agrochemical demand in Africa and Southeast Asia as food security becomes a priority
New export market registrations for existing fungicide and insecticide formulations
Industry Tailwinds
Expansion of product portfolio into biological and organic crop protection segments
Recent Developments
CRISIL Ratings upgraded Indofil Industries Limited from CRISIL A+/Positive to CRISIL AA-/Stable in January 2024, reflecting the company's established market position in fungicides, revenue growing at 12% CAGR, healthy PAT margins of 7.93%, and strong balance sheet with 0.19x gearing.
Jan 2024Indofil reported revenue of Rs.3,120 crore in FY2024. While revenue CAGR was modest at 1% (reflecting global agrochemical price corrections), EBITDA CAGR of 18% indicates significant margin improvement and operational efficiency gains.
FY2024Comparable Companies
UPL · ~20,000 Cr
Group Structure (12 entities)
Frequently Asked Questions
About Indofil Industries
Indofil Industries Limited is one of India's largest and most diversified agrochemicals companies, with a particular strength in fungicide formulations. Incorporated in 1993 under CIN U24110MH1993PLC070713, the company is headquartered in Mumbai and is promoted by the Modi family (Samir Kumaar Modi as MD and Charu Modi on the board). Indofil is a global player, exporting to over 100 countries with a revenue of Rs.3,120 crore for FY2024. The company's flagship fungicide product, Indofil M-45 (mancozeb-based), is one of India's most widely-used crop protection fungicides for controlling fungal diseases in a range of crops including potatoes, tomatoes, grapes, rice, and pulses. Beyond fungicides, Indofil has a diversified portfolio spanning herbicides, insecticides, specialty chemicals, and industrial chemicals, making it a broad-based crop protection and specialty chemicals company. Indofil holds an impressive CRISIL AA-/Stable rating (upgraded from CRISIL A+/Positive in January 2024) on bank facilities totalling Rs.2,128 crore — a testament to its financial strength, established market position, and geographical diversification. The rating rationale highlights revenue growing at 12% CAGR over four years to Rs.3,041 crore in FY2023, PAT margins of approximately 7.93%, interest coverage of 10.27x, and a lean gearing ratio of 0.19x as of March 2023. Networth stood at Rs.2,904 crore. The company maintains an extensive distribution network of 4,645 domestic distributors and 550 global distributors spanning 100+ countries, giving it unmatched reach in India's fragmented agrochemicals market. With India's agrochemical industry estimated at $5 billion and growing at 8-10% CAGR — driven by rising crop disease incidence, farmer adoption of modern inputs, and food security priorities — Indofil is well-positioned for sustained growth. The company is also considering an IPO to further strengthen its capital base.
Key Milestones
Founded in 1962 as part of the K.K. Modi Group
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Be the first to discuss Indofil Industries — share your research, ask questions, or compare notes with other investors.
Growing agrochemical demand in Africa and Southeast Asia as food security becomes a priority
New export market registrations for existing fungicide and insecticide formulations
Industry Headwinds
EU and developed market restrictions on Mancozeb could shrink premium export markets
Generic competition from China putting pressure on global agrochemical prices
Upward Factors
off cash below 175 days) and hence capital structure.
Downward Factors
funded capex or substantial acquisition, leading to gearing above 1 time and. Any adverse developments on the regulations regarding Mancozeb in India.
Global bans and restrictions on certain fungicides (including Mancozeb in EU) could reduce export addressable market
Source: AlphaHub Research
Monsoon dependency and agricultural cycle volatility create seasonal revenue fluctuations
Source: Company Financial Filings
Competition from Chinese agrochemical manufacturers who offer lower-cost generic products globally
Source: AlphaHub Research
Volatility in input chemical prices (ethylene bisdithiocarbamate precursors) can impact margins
Source: Company Financial Filings
Global bans and restrictions on certain fungicides (including Mancozeb in EU) could reduce export addressable market
Monsoon dependency and agricultural cycle volatility create seasonal revenue fluctuations
Competition from Chinese agrochemical manufacturers who offer lower-cost generic products globally
Volatility in input chemical prices (ethylene bisdithiocarbamate precursors) can impact margins
BAYERCROP · ~20,000 Cr
RALLIS · ~3,500 Cr
Parent company
Wholly owned subsidiary
Wholly owned subsidiary
Wholly owned subsidiary
Step Down subsidiary
Step Down subsidiary
Step Down subsidiary
96.55% Step Down subsidiary
Wholly owned subsidiary
Wholly owned subsidiary
Wholly owned subsidiary
Joint Venture, strong operational and financial linkages
Became one of India's leading Mancozeb fungicide manufacturers over subsequent decades
Incorporated formally under current structure in 1993 per CIN registration
Established distribution in 70+ countries globally
Operates multiple manufacturing facilities in India with in-house R&D
K.K. Modi Group